Ekman Lars Insider Trading
Get the latest insider transactions of Ekman Lars. Ekman Lars is in AMARIN CORP PLC\UK ($AMRN) and Director in AMARIN CORP PLC\UK ($AMRN) and Director in INTERMUNE INC ($ITMN) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Prothena Corp plc ($PRTA) and Director in SOPHIRIS BIO INC. ($SPHS) and Director in Spark Therapeutics, Inc. ($ONCE). Discover the current value of Ekman Lars shares.
Address: 3280 BAYSHORE BLVD. BRISBANE 94005CA
Ekman Lars is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
ITMN | INTERMUNE INC | Director | 0 | 0.00 |
PRTA | PROTHENA CORP PUBLIC LTD CO | Director | 243 | 12,028.50 |
SPHS | SOPHIRIS BIO INC. | Director | 0 | 0.00 |
AMRN | AMARIN CORP PLC\UK | 38,600 | 128,152.00 | |
RARE | Ultragenyx Pharmaceutical Inc. | Director | 14,445 | 1,053,184.95 |
ONCE | Spark Therapeutics, Inc. | Director | 0 | 0.00 |
Insider Trading Transactions of Ekman Lars
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Buy | 0.00 | 2,145 | 0 | 14,445 |
Jun 28 2021 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Option Exercise | 93.20 | 4,125 | 384,450 | 4,125 |
Jun 16 2021 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | 5.00 | 48,506 | 242,530 | 48,506 | |
Jun 16 2021 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | 0.00 | 38,000 | 0 | 38,000 | |
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | 6.62 | 36,739 | 243,212 | 36,739 | |
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | 0.00 | 28,702 | 0 | 28,702 | |
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | 6.62 | 36,739 | 243,212 | 36,739 | |
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | 0.00 | 28,702 | 0 | 28,702 | |
Jun 30 2020 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Buy | 0.00 | 2,550 | 0 | 12,300 |
Jun 30 2020 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Option Exercise | 76.58 | 4,250 | 325,465 | 4,250 |
May 22 2020 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | 11.33 | 17,500 | 198,275 | 17,500 |
Dec 17 2019 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Sell | 114.50 | 3,000 | 343,500 | 0 |
Dec 17 2019 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 81.53 | 4,000 | 326,120 | 0 |
Dec 17 2019 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 50.93 | 4,000 | 203,720 | 0 |
Dec 17 2019 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 56.22 | 6,000 | 337,320 | 0 |
Dec 17 2019 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 3.45 | 37,203 | 128,350 | 0 |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 14.40 | 38,600 | 555,840 | 38,600 |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 14.40 | 38,600 | 555,840 | 38,600 |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 19.35 | 38,600 | 746,759 | 0 |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 19.35 | 38,600 | 746,759 | 0 |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 14.40 | 38,600 | 555,840 | 0 |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 14.40 | 38,600 | 555,840 | 0 |
Nov 07 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 14.40 | 6,400 | 92,160 | 6,400 |
Nov 07 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 18.00 | 6,400 | 115,230 | 0 |
Nov 07 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 14.40 | 6,400 | 92,160 | 38,600 |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 5.58 | 13,500 | 75,330 | 13,500 |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 3.06 | 25,845 | 79,086 | 39,345 |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 3.21 | 51,671 | 165,864 | 91,016 |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 15.01 | 91,016 | 1,365,722 | 0 |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 5.58 | 13,500 | 75,330 | 0 |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 3.06 | 25,845 | 79,086 | 0 |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 3.21 | 51,671 | 165,864 | 0 |
Jun 28 2019 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | 0.78 | 20,000 | 15,564 | 20,000 |
Jun 13 2019 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Buy | 0.00 | 3,000 | 0 | 9,750 |
Jun 13 2019 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Option Exercise | 58.74 | 5,000 | 293,700 | 5,000 |
Jun 03 2019 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Buy | 0.00 | 1,500 | 0 | 3,000 |
Jun 03 2019 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 0.00 | 1,500 | 0 | 0 |
May 24 2019 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | 9.23 | 17,500 | 161,525 | 17,500 |
May 21 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 16.83 | 10,431 | 175,554 | 10,431 |
May 21 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 0.00 | 8,023 | 0 | 8,023 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 1.03 | 19,584 | 20,172 | 19,584 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 1.87 | 6,390 | 11,949 | 25,974 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 1.87 | 28,500 | 53,295 | 54,474 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 2.19 | 35,258 | 77,215 | 89,732 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 2.50 | 17,358 | 43,395 | 107,090 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 2.50 | 28,287 | 70,718 | 135,377 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 21.16 | 98,677 | 2,088,074 | 36,700 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 21.71 | 36,700 | 796,830 | 0 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 1.03 | 19,584 | 20,172 | 0 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 1.87 | 6,390 | 11,949 | 0 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 1.87 | 28,500 | 53,295 | 0 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 2.19 | 35,258 | 77,215 | 0 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 2.50 | 17,358 | 43,395 | 0 |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 2.50 | 28,287 | 70,718 | 0 |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | 1.03 | 100,416 | 103,428 | 140,416 |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 14.92 | 21,200 | 316,397 | 119,216 |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 15.96 | 7,247 | 115,678 | 111,969 |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 17.29 | 48,711 | 842,140 | 63,258 |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 18.16 | 55,762 | 1,012,671 | 7,496 |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | 18.62 | 7,496 | 139,603 | 0 |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 1.03 | 100,416 | 103,428 | 19,584 |
Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 3.21 | 51,671 | 165,864 | 51,671 |
Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 0.00 | 34,269 | 0 | 34,269 |
Jun 28 2018 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | 2.91 | 20,000 | 58,200 | 20,000 |
Jun 20 2018 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Buy | 0.00 | 3,000 | 0 | 6,750 |
Jun 20 2018 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Option Exercise | 80.69 | 5,000 | 403,450 | 5,000 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Buy | 0.00 | 1,500 | 0 | 1,500 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 81.53 | 4,000 | 326,120 | 4,000 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 0.00 | 1,500 | 0 | 1,500 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 0.00 | 1,500 | 0 | 0 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Buy | 0.00 | 1,500 | 0 | 1,500 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 81.53 | 4,000 | 326,120 | 4,000 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 0.00 | 1,500 | 0 | 1,500 |
May 31 2018 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 0.00 | 1,500 | 0 | 0 |
May 18 2018 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | 16.43 | 12,000 | 197,160 | 12,000 |
Jun 22 2017 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Buy | 0.00 | 1,875 | 0 | 3,750 |
Jun 22 2017 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Director | Option Exercise | 65.66 | 3,750 | 246,225 | 3,750 |
Jun 02 2017 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 50.93 | 4,000 | 203,720 | 4,000 |
Jun 02 2017 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 0.00 | 1,500 | 0 | 1,500 |
Jun 01 2017 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | 2.44 | 20,000 | 48,800 | 20,000 |
May 19 2017 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | 56.23 | 12,000 | 674,760 | 12,000 |
May 17 2017 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 3.06 | 25,845 | 79,086 | 25,845 |
May 17 2017 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 0.00 | 17,974 | 0 | 17,974 |
Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 2.19 | 35,258 | 77,215 | 35,258 |
Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 0.00 | 25,115 | 0 | 25,115 |
Jun 14 2016 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Buy | 0.00 | 1,875 | 0 | 1,875 | |
Jun 14 2016 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Option Exercise | 65.85 | 3,750 | 246,938 | 3,750 | |
Jun 03 2016 | ONCE | Spark Therapeutics, Inc. | Ekman Lars | Director | Option Exercise | 56.22 | 6,000 | 337,320 | 6,000 |
May 31 2016 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | 0.99 | 8,250 | 8,168 | 8,250 |
May 24 2016 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | 42.50 | 15,000 | 637,500 | 15,000 |
Mar 21 2016 | RARE | Ultragenyx Pharmaceutical ... | Ekman Lars | Option Exercise | 54.28 | 15,000 | 814,200 | 15,000 | |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Buy | 6.41 | 30,000 | 192,300 | 30,243 |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Sell | 72.96 | 16,588 | 1,210,264 | 13,655 |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Sell | 73.73 | 11,502 | 847,999 | 2,153 |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Sell | 74.43 | 1,910 | 142,171 | 243 |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | 6.41 | 30,000 | 192,300 | 95,000 |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 2.50 | 17,358 | 43,395 | 17,358 |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 2.50 | 28,287 | 70,718 | 28,287 |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 0.00 | 40,500 | 0 | 40,500 |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | 0.00 | 22,000 | 0 | 22,000 |
May 28 2015 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | 1.08 | 8,250 | 8,910 | 8,250 |
May 26 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | 34.04 | 15,000 | 510,600 | 15,000 |
May 12 2011 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 39.46 | 12,000 | 473,520 | 12,000 |
Sep 27 2010 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 12.96 | 15,000 | 194,415 | 15,000 |
May 10 2010 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 10.37 | 12,000 | 124,440 | 93,003 |
Jun 24 2009 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 11.33 | 12,000 | 135,960 | 81,003 |
May 15 2008 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 15.34 | 12,000 | 184,080 | 69,003 |
May 17 2007 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 25.55 | 12,000 | 306,600 | 57,003 |
Sep 20 2006 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 17.05 | 30,000 | 511,500 | 30,000 |
Sep 20 2006 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | 17.05 | 15,003 | 255,801 | 15,003 |